DocSym
β
Searchsearch
Search
(D07.3) Carcinoma in situ: other and unspecified female genital organs
More details coming soon
93 952 in individuals diagnosis carcinoma in situ: other and unspecified female genital organs confirmed
1 871 deaths with diagnosis carcinoma in situ: other and unspecified female genital organs
2% mortality rate associated with the disease carcinoma in situ: other and unspecified female genital organs
Diagnosis carcinoma in situ: other and unspecified female genital organs is diagnosed Women are 70.06% more likely than Men
14 064
Men receive the diagnosis carcinoma in situ: other and unspecified female genital organs
321 (2.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
79 888
Women receive the diagnosis carcinoma in situ: other and unspecified female genital organs
1 550 (1.9 %)Died from this diagnosis.
Risk Group for the Disease carcinoma in situ: other and unspecified female genital organs - Men aged 65-69 and Women aged 55-59
In Men diagnosis is most often set at age 25-94
Less common in men the disease occurs at Age 0-24, 95+Less common in women the disease occurs at Age 0-9, 95+
In Women diagnosis is most often set at age 10-94
Disease Features carcinoma in situ: other and unspecified female genital organs
Absence or low individual and public risk
Carcinoma in situ: other and unspecified female genital organs - what does this mean
Carcinoma in situ of the female genital organs is a condition in which abnormal cells are present on the surface layer of the tissue but have not yet invaded the deeper layers. it is often caused by genetic mutations that can be caused by external factors such as certain viruses, environmental toxins, and radiation. it is important to detect and treat this condition early as it can lead to the development of more serious conditions if left untreated.
What happens during the disease - carcinoma in situ: other and unspecified female genital organs
Carcinoma in situ of the female genital organs is caused by the abnormal growth of cells on the surface of the organ, which have not yet invaded deeper layers of the tissue. this growth is often caused by an accumulation of genetic mutations which can be triggered by environmental factors such as radiation, certain viruses, and hormones. these abnormal cells can spread to other parts of the body if left untreated, leading to more serious health issues.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Clinical examination
- Pap smear
- Ultrasound
- Biopsy
- Colposcopy
- Endometrial biopsy
- CT scan
- MRI scan
- PET scan
Treatment and Medical Assistance
Main Goal: To treat Carcinoma in situ of other and unspecified female genital organs
- Surgery to remove the affected tissue
- Radiation therapy to destroy the cancer cells
- Chemotherapy to stop the growth of cancer cells
- Immunotherapy to boost the body's natural defenses
- Hormonal therapy to reduce the growth of cancer cells
- Targeted therapy to attack specific cancer cells
- Cryosurgery to freeze and kill cancer cells
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Carcinoma in situ: other and unspecified female genital organs - Prevention
Carcinoma in situ of the female genital organs can be prevented by practicing safe sex, avoiding smoking, and having regular gynecological exams. additionally, it is important to be aware of any changes in the genital area and to seek medical attention if any symptoms are present.